U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07506551) titled 'Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome' on March 26.
Brief Summary: Determination of proteins and their levels in the vitreous of eyes with or without pseudoexfoliation syndrome (PEX)
Study Start Date: July 06, 2023
Study Type: INTERVENTIONAL
Condition:
Pseudoexfoliation Syndrome
Intervention:
OTHER: Liquid chromatography mass spectrometry
Proteomic analysis of vitreous samples of patients with epiretinal membranes or macular holes with or without pseudoexfoliation syndrome using Liquid chromatography mass spectrometry
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Prim. Prof. Dr. Oliv...